Abstract
In this issue of Blood, Herrmann et al(1) have developed a novel checkpoint inhibitory T-cell-engaging (CiTE) antibody for acute myeloid leukemia (AML......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
